Insiders · Profile

Aviezer David

President & CEO at Protalix BioTherapeutics. Filing since 16 Apr 2009. CIK 0001385112

Company
Date
Role
Action
Shares
Amount
Of holding
2 May 2012
President & CEO
Sold, plan not stated
450,000
$3.21M
100%
21 Oct 2009
CEO and President
Sold, plan not stated
34,238
$320.47K
100%
20 Oct 2009
CEO and President
Sold, plan not stated
60,000
$567.00K
100%
19 Oct 2009
CEO and President
Sold, plan not stated
150,000
$1.41M
100%
12 May 2009
President & CEO
Sold, plan not stated
55,900
$190.62K
100%
11 May 2009
President & CEO
Sold, plan not stated
38,900
$132.65K
100%
8 May 2009
President & CEO
Sold, plan not stated
5,200
$17.68K
100%
6 May 2009
President & CEO
Sold, plan not stated
20,000
$60.20K
100%
5 May 2009
President & CEO
Sold, plan not stated
21,600
$66.31K
100%
4 May 2009
President & CEO
Sold, plan not stated
33,400
$100.53K
100%
20 Apr 2009
President & CEO
Sold, plan not stated
33,300
$83.58K
100%
17 Apr 2009
President & CEO
Sold, plan not stated
10,000
$25.60K
100%
16 Apr 2009
President & CEO
Sold, plan not stated
6,700
$16.75K
100%
13 decisions on file.